Establishment of a human acute promyelocytic leukemia-ascites model in SCID mice

Blood

Volumn 87, Issue 8, 1996, Pages 3404-3409

  Zhang, Su Yin ^b   Zhu, Jun ^b   Chen, Guo Qiang ^b   Du, Xin Xu ^b   Lu, Li Juan ^b   Zhang, Zhou ^b   Zhong, Hao Jie ^b   Chen, Hui Ren ^b   Wang, Zhen Yi ^b   Berger, Roland ^b   Lanotte, Michel ^b   Waxman, Samuel ^b   Chen, Zhu ^b   Chen, Sai Juan ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; DOXORUBICIN; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER TRANSPLANTATION; CELL TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GENE FUSION; HUMAN; MALE; MOUSE; PRIORITY JOURNAL; SCID MOUSE;

EID: 15844398784     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.8.3404.bloodjournal8783404     Document Type: Article

References (25)

1. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhao L, Gu LJ, Wang ZY: Use of all-trans retinoic acid in treatment of acute promyelocytic leukemia. Blood 72:567, 1988
2. Warrell RP, de The H, Wang ZY, Degos L: Acute promyelocytic leukemia. N Engl J Med 329:177, 1993
3. Grignani F, Fagioli M, Alcalay M, Long L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Grignani F, Pelicci PG: Acute promyelocytic leukemia: From genetics to treatment. Blood 83:10, 1994
4. Zelent A: Translocation of the RARa locus to the PML or PLZF gene in acute promyelocytic leukaemia. Br J Haematol 86:451, 1994
5. Chen SJ, Wang ZY, Chen Z: Acute promyelocytic leukemia: From clinic to molecular biology. Stem Cell 13:22, 1995
6. Bosma MJ: The SCID mouse: A model for severe combined immune deficiency, in Wu BQ, Zheng J (eds): Immune-Deficiency Animals in Experimental Medicine. Basel, Karger, 1989
7. Jansen B, Uckun FM, Jaszcz WB, Kersey JH: Establishment of a human t(4;11) leukemia in severe combined immunodeficient mice and successful treatment using anti-CD19 (B43)-pokeweed antiviral protein immunotoxin. Cancer Res 52:406, 1992
8. Cesano A, O'Connor R, Lange B, Finan J, Rovera G, Santali D: Homing and progression patterns of childhood acute lymphoblastic leukemias in severe combined immunodeficiency mice. Blood 77:2463, 1991
9. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645, 1994
10. Huang YW, Richardson JA, Tong AW, Zhang BQ, Stone MJ, Vitetta ES: Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease. Cancer Res 53:1392, 1992
11. Ahsmann EJ, Van Tol MJD, Oudeman-Gruber J, Lkhirst H, Uytdehaag FGCM, Schuurman HJ, Bloem AC: The SCID mouse as a model for multiple myeloma. Br J Haematol 89:319, 1995
12. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R: NB4, a maturation inducible cell line with t(15; 17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080, 1991
13. Senn JS, Messner HA, Pinkerton PH, Chang L, Nitsch B, McCulloch EA, and the Toronto Area Preleukemia Study Group: Peripheral blood blast cell progenitors in human preleukemia. Blood 59:106, 1982
14. ISCN: Guidelines for Cancer Cytogenetics, Supplement to an International System for Human Cytogenetic Nomenclature. Karger, Basel, 1991
15. Huang W, Sun GL, Li XS, Cao Q, Lu Y, Jang GS, Zhang FQ, Chai JR, Wang ZY, Waxman S, Chen Z, Chen SJ: Acute promyelocytic leukemia: Clinical relevance of two major PML-RARa isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse. Blood 82:1264, 1993
16. Zhu J, Shi XG, Chu HY, Tong JH, Wang ZY, Naoe T, Waxman S, Chen SJ, Chen Z: Effect of retinoic acid isomers on proliferation, differentiation and PML relocalization in the APL cell line NB4. Leukemia 9:302, 1995
17. Chen SJ, Chen Z, Chen A, Tong JH, Dong S, Wang ZY, Waxman S, Zelent A: Occurrence of distinct PML-RARα fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction. Oncogene 7:1223, 1992
18. Chen A, Licht JD, Wu Y, Hellinger N, Scher W, Waxman S: Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by non-retinoic agents. Blood 84:2122, 1994
19. Ruchaud S, Duprez E, Gendron MC, Houge G, Genieser HG, Jastorff B, Doskeland SO, Lanotte M: Two distinctly regulated events, priming ana triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line. Proc Natl Acad Sci USA 91.8428, 1994
20. Kizaki M, Nakajima H, Mori S, Koike T, Morikawa M, Ohta M, Saito M, Koeffler HP, Ikeda Y: Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HL-60 cells. Blood 83:3289, 1994
21. Waxman S, Scher BM, Hellinger N, Scher W: Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide. Cancer Res 50:3878, 1990
22. Huang Y, Waxman S: Enhanced apoptosis in leukemia cells following treatment with combination fluoropyrimidines and differentiation inducers Mol Cell Diff 2:83, 1994
23. Huang Y, Scher BM, Waxman S: Combination cytotoxic-differentiation therapy-induced apoptosis correlates with decrease in intracellular pH and activation of an endonuclease. Mol Cell Diff 3:241, 1995
24. Rousselot P, Hardas B, Patel A, Guidwz F, Gaken J, Castaigne S, Dejean A, de The H, Degos L, Farzaneh F, Chomienne C: The PML-RARa gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells Oncogene 9:545, 1994
25. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti L, Pelicci PG: The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423, 1993